Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,041 | -17,857 | -12,038 | -8,584 | -3,219 |
| Depreciation Amortization | 69 | 174 | 117 | 76 | 37 |
| Accounts payable and accrued liabilities | 180 | -60 | 308 | -209 | -291 |
| Other Working Capital | 186 | 380 | 871 | 378 | -351 |
| Other Operating Activity | 144 | 2,942 | 2,222 | 2,408 | 593 |
| Operating Cash Flow | $-4,461 | $-14,421 | $-8,521 | $-5,931 | $-3,232 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,555 | -1,555 | -1,536 | -4,553 | -4,500 |
| PPE Investments | -219 | -354 | -141 | -100 | -70 |
| Investing Cash Flow | $1,336 | $-1,909 | $-1,678 | $-4,653 | $-4,570 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,971 | 34,305 | 34,280 | 34,280 | 0 |
| Financing Cash Flow | $28,971 | $34,305 | $34,280 | $34,280 | $0 |
| Beginning Cash Position | 26,856 | 8,881 | 8,881 | 8,881 | 8,881 |
| End Cash Position | 52,701 | 26,856 | 32,962 | 32,577 | 1,079 |
| Net Cash Flow | $25,845 | $17,975 | $24,082 | $23,697 | $-7,802 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,461 | -14,421 | -8,521 | -5,931 | -3,232 |
| Capital Expenditure | -219 | -354 | -141 | -100 | -70 |
| Free Cash Flow | -4,681 | -14,775 | -8,662 | -6,031 | -3,302 |